The revolutionary new treatment, known as Inclisiran, is delivered as an injection twice a year and can be used alongside statins....
It comes after the NHS struck a historic deal with Switzerland-based drugmaker Novartis to enable 300, 000 patients to benefit from the lifesaving treatment over the next three years....
That figure could then rise to nearly half a million in the future.It has been estimated that Inclisiran could prevent 55, 000 heart attacks and strokes, saving 30, 000 lives wi
综合
每日快报-科学
2021-09-01 00:00:00.0